What Strategy Inc does

Strategy Inc. is a privately held boutique consulting firm specializing in life science and medical device commercialization due diligence. Founded in 2000 by Nancy Patterson and headquartered in Austin, Texas with offices in New York and Research Triangle Park, North Carolina, the firm delivers market due diligence, financial valuation, competitive strategy, portfolio prioritization, voice-of-customer research, and KOL identification services to clients across the medical device, pharmaceutical, and biotechnology sectors. Its client roster spans multinational medical device companies (Edwards Lifesciences, Boston Scientific, Johnson & Johnson's Advanced Sterilization Products), venture capital firms (Morgenthaler Ventures, MedFocus Fund), academic and nonprofit research institutes (LA BioMed, Alfred E. Mann Institute at USC), and early-stage startups (Poietis, SabirMedical, OrthoXel).

The firm's core analytical offerings are anchored by a proprietary "12 Weighted Driver Method" for commercialization probability assessment and a "TechSelect Portfolio Analysis" framework that combines market sizing, competitive landscape mapping, clinical adoption validation, reimbursement evaluation, and risk analysis. Methodology is delivered through customized primary research, including KOL interviews, conjoint analysis, MAUDE data deep-dives, and competitive teardowns. Engagements are project-based, ranging from narrow deliverables (e.g., competitive analysis, valuation memos) to extensive market assessments exceeding 100 pages. Pricing is not publicly disclosed and is quoted on a per-engagement basis, consistent with senior-consultant-led professional services delivery.

The firm's go-to-market is sales-led and relationship-driven, with no productized offerings or self-service channels. Lead generation depends on thought leadership — including Nancy Patterson's guest lectures at UCLA, IESE, Caltech, Stanford, and WARF — alongside a curated VC and angel investor referral network and a content-marketing blog. Approximately 46% of business over the past decade has been international, focused primarily on helping European, Israeli, Asian, and South American entities bring medical technologies into the US market. The firm is founder-controlled, has no disclosed institutional investment, no subsidiaries, and operates with a small senior consultant team.

Name

Strategy Inc

Legal name

Strategy Inc. Inc.

Website

https://strategyinc.net

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

Strategy Inc. is a boutique life science and medical device consulting firm founded in 2000 that provides market due diligence, financial valuation, competitive strategy, and portfolio prioritization services to multinational medical device companies, venture capitalists, and emerging technology startups.

Ownership category

akta.pro rank

Product category

Life Science and Medical Device Consulting

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

Keywords

• Life science consulting
• Medical device consulting
• Market due diligence
• Financial valuation services
• Commercialization strategy

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Life Science Consulting Services: Fee-for-service consulting engagements for market analysis, financial valuation, competitive strategy, and portfolio analysis. Services are customized to client needs and likely billed on project basis or retainer. Clients include venture capitalists, emerging technology companies, law firms, multinational medical device companies, and incubator/accelerators.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Strategy Inc. is a boutique life science and medical device consulting firm that provides customized market due diligence, financial valuation, competitive strategy, and commercialization analysis services. The firm helps medical device, pharmaceutical, and biotech companies validate market opportunities, assess competitive landscapes, identify Key Opinion Leaders, and develop commercialization strategies for emerging preclinical and clinical-stage technologies. Services are delivered as project-based consulting engagements, with deliverables ranging from market assessments and valuations to KOL introductions and US market launch support.

Product overview

Strategy Inc is a life science and medical device consulting firm offering a suite of strategic consulting services for essential financial and market due diligence. The company's service offerings include Commercialization Strategy, Financial Valuation, Competitive Strategy, Portfolio Analysis, Voice of the Customer, Market Analysis, Value Analysis, Key Opinion Leader Identification, Risk Analysis, Positioning Analysis, Exit Strategy, and Business Plan Development. These services are designed to help medical device, pharmaceutical, and biotech companies navigate the commercialization process from early-stage valuation through market launch. The company was founded in 2000 and is headquartered in Austin, Texas with offices in New York and Research Triangle Park, North Carolina.

Differentiator

Problem solved

Functional benefit

Products and services

• Commercialization Strategy
• Financial Valuation
• Competitive Strategy
• Portfolio Analysis
• Voice of the Customer
• Market Analysis
• Value Analysis
• Key Opinion Leader Identification
• Risk Analysis
• Positioning Analysis
• Exit Strategy
• Business Plan Development

Quantifiable outcome

• Edwards Lifesciences achieved validated market assumptions and strategic decisions for portfolio expansion through worldwide market due diligence
• +2 more outcomes

Named customers24 records

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered notable and core.

• LA BioMed (Los Angeles Biomedical Research Institute)notableStrategic or Co-development PartnerLA BioMed, a leading nonprofit biomedical research institute with 150 researchers, retained Strategy Inc. to perform TechSelect Analysis on eight developing technologies to prioritize resources for highest probability of commercial success.
• Alfred E. Mann Institute for Biomedical Engineering at USCnotableStrategic or Co-development PartnerThe Alfred E. Mann Institute, a nonprofit supporting biomedical device research and commercialization, engaged Strategy Inc. for valuable medical device assessments including market potential, competition, regulatory affairs, IP, and reimbursement analysis.
• Advanced Sterilization Products (Johnson & Johnson)coreStrategic or Co-development PartnerAdvanced Sterilization Products, a Johnson & Johnson company developing infection control products, has engaged Strategy Inc. for market opportunity assessments, new product concept validation, and voice of customer/KOL feedback across North America, Asia, and Latin America.
• Edwards LifesciencescoreStrategic or Co-development PartnerEdwards Lifesciences, the global leader in heart valve and hemodynamic monitoring technology with $4.3B in 2019 sales, retained Strategy Inc. for worldwide market due diligence to validate clinical need before allocating resources for portfolio expansion.
• Boston ScientificcoreStrategic or Co-development PartnerBoston Scientific, the world's largest medical device company dedicated to less-invasive medicine, engaged Strategy Inc. for marketing claims analysis and market research yielding comprehensive market space analysis with exceptional clarity and utility.
• Hansji Corporation/KP MedcurenotableStrategic or Co-development PartnerHansji Corporation (an incubator/accelerator) and its portfolio company KP Medcure engaged Strategy Inc. for valuation and due diligence on innovative vascular technology, which was subsequently acquired by Medtronic.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Health Advances: Boston-based strategy consulting firm focused exclusively on medical devices, diagnostics, and life sciences. Direct peer with similar boutique model, clinical/commercial due diligence focus, and Fortune 500 medtech clients.
• ClearView Healthcare Partners: New York-based life sciences consulting firm providing commercialization strategy, due diligence, and portfolio analysis to pharma, biotech, and medtech clients. Closely comparable in service mix and client base to Strategy Inc.
• DeciBio Consulting: Life science consulting firm specializing in market analysis, due diligence, and competitive intelligence for diagnostics and therapeutics. Comparable boutique model with medtech/biotech orientation.
• Putnam Associates: Healthcare-focused strategy consulting firm serving medical device, biotech, and pharma clients with commercial due diligence and market access engagements. Similar boutique operating model.
• Trinity Partners: Healthcare and life sciences strategy consulting firm offering commercial due diligence, market assessment, and portfolio analysis for biopharma and medtech investors. Comparable specialized boutique.

Broad incumbents

• LEK Consulting: Global management consulting firm with a dedicated Life Sciences practice providing commercial due diligence, valuation, and strategy services to life science investors and corporates. Notable larger competitor.
• Charles River Associates: Global consulting firm with a Life Sciences practice providing due diligence, valuation, and strategy services to biotech and medtech clients. Operates at a larger scale but competes in the same advisory categories.
• McKinsey & Company (Life Sciences Practice): Global management consulting firm with a dedicated Pharmaceuticals & Medical Products practice competing for the same enterprise and VC-led medtech due diligence work, though at much larger scale.
• Boston Consulting Group (Healthcare Practice): Global consulting firm with a major healthcare and medtech practice that competes for enterprise strategy and commercial due diligence engagements within Strategy Inc.'s addressable market.

Regional players

• Healthlink Group (a QHT Consulting firm): Specialized medical device and pharmaceutical consulting firm with strong presence in Europe and Israel, providing market access and commercialization strategy for medtech innovators. Comparable in vertical and international foreign-to-US focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Strategy Inc